Organogenesis (ORGO) falls 2.36% in Light Trading on August 4 – Equities.com

Posted: August 5, 2021 at 2:45 am

Last Price$ Last TradeChange$ Change Percent %Open$ Prev Close$ High$ low$ 52 Week High$ 52 Week Low$ Market CapPE RatioVolumeExchange

ORGO - Market Data & News

Today, Organogenesis Holdings Inc - Class A Incs (NASDAQ: ORGO) stock fell $0.35, accounting for a 2.36% decrease. Organogenesis opened at $14.66 before trading between $15.36 and $14.39 throughout Wednesdays session. The activity saw Organogenesiss market cap fall to $1,854,036,126 on 575,844 shares -below their 30-day average of 721,957.

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Visit Organogenesis Holdings Inc - Class A's profile for more information.

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Organogenesis Holdings Inc - Class A and to follow the company's latest updates, you can visit the company's profile page here: Organogenesis Holdings Inc - Class A's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE:The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Continue reading here:
Organogenesis (ORGO) falls 2.36% in Light Trading on August 4 - Equities.com

Related Posts